Tag Archives: AI drug discovery

March 10, 2021
Broadcast
Read Article
March 9, 2021
FeaturedIn The News
Read Article
March 8, 2021
FeaturedIn The News
Read Article
January 12, 2021
In The News
Read Article
December 21, 2020
In The News

After raising $123 million this past summer to fuel its artificial-intelligence-based drug design work, Atomwise has helped launch a new company focused on uncovering treatments in immuno-oncology.

Read Article
December 18, 2020
In The News

A2i Therapeutics secures seed funding from FutuRx and its investors – Johnson & Johnson Innovation (JJDC, Inc.), Takeda Ventures, OrbiMed Partners, Leaps by Bayer and the Israeli Innovation Authority – to develop novel small molecule immuno-oncology agents.

Read Article